FDA OKs QVAR RediHaler for Asthma in Children Aged 4+

Teva’s breath-actuated inhaler for the maintenance treatment of asthma will be available in early 2018 and will replace the older QVAR metered-dose inhaler.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply